You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 19, November 19, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Neurology
 •Alzheimer Disease
 •Cerebrovascular Disease
 •Dementias
 •Complementary and Alternative Medicine
 •Stroke
 •Prognosis/ Outcomes
 •Drug Therapy, Other
 •Alert me on articles by topic

Ginkgo biloba Extract and Preventing Alzheimer Disease

Lon S. Schneider, MD

JAMA. 2008;300(19):2306-2308.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Ginkgo biloba leaves and extracts are widely used over-the-counter preparations marketed in the United States as food supplements or nutraceuticals, and as such, explicit health claims are not listed in their labeling. In other countries and in the popular press, G biloba is advocated for the treatment of a broad and seemingly ever-increasing range of medical conditions.

The extract used in the Ginkgo Evaluation of Memory (GEM) study reported in this issue of JAMA by DeKosky and colleagues1 and in many other clinical and preclinical studies is Ginkgo extract EGb 761 (Schwabe Pharmaceuticals, Karlsruhe, Germany). The extract is standardized to contain 2 major constituents: 22% to 27% flavonoids and 5% to 7% terpene lactones (ginkgolides and bilobalide).2 Unique to G biloba trees, the terpene lactones consist of several ginkgolides and bilobalide.2-3 The flavonoids and ginkgolides have protean biological activity in preclinical research. The flavonoids are active . . . [Full Text of this Article]

Author Affiliation: Departments of Psychiatry and Behavioral Sciences, and Neurology, Keck School of Medicine, and the Leonard Davis School of Gerontology, University of Southern California, Los Angeles.


RELATED ARTICLE

Ginkgo biloba for Prevention of Dementia: A Randomized Controlled Trial
Steven T. DeKosky, Jeff D. Williamson, Annette L. Fitzpatrick, Richard A. Kronmal, Diane G. Ives, Judith A. Saxton, Oscar L. Lopez, Gregory Burke, Michelle C. Carlson, Linda P. Fried, Lewis H. Kuller, John A. Robbins, Russell P. Tracy, Nancy F. Woolard, Leslie Dunn, Beth E. Snitz, Richard L. Nahin, Curt D. Furberg, and for the Ginkgo Evaluation of Memory (GEM) Study Investigators
JAMA. 2008;300(19):2253-2262.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ginkgo to Prevent Dementia? Forget About It.
JWatch Psychiatry 2008;2008:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.